HealthAlzheimer's Drug Donanemab Shows Promise in Slowing Progression Eli Lilly's drug has the potential to halt the progression of Alzheimer's disease in its early stages.by Quincy Jon
TechMicrosoft's $69 Billion Activision Blizzard Acquisition Deadline Extended Amid Regulatory Challengesby Quincy Jon
Tech BuzzPioneering Innovation: How Ruchi Agarwal Became a Leading Engineer and Innovator in the Tech Industryby David Thompson
TechVarun Milind Kulkarni: Digital Product Management Strategies for AI-Based Reporting and Analytics in Cloud Contact Centersby Varun Milind Kulkarni
TechNetflix Discontinues Ad-Free Basic Plan, Rolls Out New Pricing Tiers, Ad-Included Optionsby John Lopez
Tech BuzzA New Approach: One Company’s Quest to Counteract the Ecological Impact of Mining by Promoting Recycled Goldby Noah Miller
Best Co‑Op Games on Game Pass: 'Helldivers 2' Co‑Op, 'Sea of Thieves,' 'It Takes Two' and Top Online Co‑Op Games for Multiplayer Game Pass